These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 7884561)

  • 1. In vitro hormonal effects of soybean isoflavones.
    Molteni A; Brizio-Molteni L; Persky V
    J Nutr; 1995 Mar; 125(3 Suppl):751S-756S. PubMed ID: 7884561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The evidence for soybean products as cancer preventive agents.
    Kennedy AR
    J Nutr; 1995 Mar; 125(3 Suppl):733S-743S. PubMed ID: 7884559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glycone-rich Soy Isoflavone Extracts Promote Estrogen Receptor Positive Breast Cancer Cell Growth.
    Johnson KA; Vemuri S; Alsahafi S; Castillo R; Cheriyath V
    Nutr Cancer; 2016; 68(4):622-33. PubMed ID: 27043076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The molecular mechanisms of estrogens. Clinical aspects, industrial estrogens and phytoestrogens].
    Hagen ML; Hellmers M; Abrahamsen B; Hagen C
    Ugeskr Laeger; 2004 Mar; 166(13):1220-4. PubMed ID: 15088482
    [No Abstract]   [Full Text] [Related]  

  • 5. Estrogenic and antiproliferative properties of genistein and other flavonoids in human breast cancer cells in vitro.
    Zava DT; Duwe G
    Nutr Cancer; 1997; 27(1):31-40. PubMed ID: 8970179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isoflavones inhibit proliferation of ovarian cancer cells in vitro via an estrogen receptor-dependent pathway.
    Chen X; Anderson JJ
    Nutr Cancer; 2001; 41(1-2):165-71. PubMed ID: 12094620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isoflavones suppress the expression of the FcεRI high-affinity immunoglobulin E receptor independent of the estrogen receptor.
    Yamashita S; Tsukamoto S; Kumazoe M; Kim YH; Yamada K; Tachibana H
    J Agric Food Chem; 2012 Aug; 60(34):8379-85. PubMed ID: 22871233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Soy intake and cancer risk: a review of the in vitro and in vivo data.
    Messina MJ; Persky V; Setchell KD; Barnes S
    Nutr Cancer; 1994; 21(2):113-31. PubMed ID: 8058523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soy Isoflavones in Integrative Oncology: Increased Efficacy and Decreased Toxicity of Cancer Therapy.
    Sahin I; Bilir B; Ali S; Sahin K; Kucuk O
    Integr Cancer Ther; 2019; 18():1534735419835310. PubMed ID: 30897972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genistein and daidzein induce cell proliferation and their metabolites cause oxidative DNA damage in relation to isoflavone-induced cancer of estrogen-sensitive organs.
    Murata M; Midorikawa K; Koh M; Umezawa K; Kawanishi S
    Biochemistry; 2004 Mar; 43(9):2569-77. PubMed ID: 14992594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dietary soybean may be antiestrogenic in male mice.
    Mäkelä SI; Pylkkänen LH; Santti RS; Adlercreutz H
    J Nutr; 1995 Mar; 125(3):437-45. PubMed ID: 7876918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soy for breast cancer survivors: a critical review of the literature.
    Messina MJ; Loprinzi CL
    J Nutr; 2001 Nov; 131(11 Suppl):3095S-108S. PubMed ID: 11694655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Addressing the soy and breast cancer relationship: review, commentary, and workshop proceedings.
    Messina M; McCaskill-Stevens W; Lampe JW
    J Natl Cancer Inst; 2006 Sep; 98(18):1275-84. PubMed ID: 16985246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Equol, a natural estrogenic metabolite from soy isoflavones: convenient preparation and resolution of R- and S-equols and their differing binding and biological activity through estrogen receptors alpha and beta.
    Muthyala RS; Ju YH; Sheng S; Williams LD; Doerge DR; Katzenellenbogen BS; Helferich WG; Katzenellenbogen JA
    Bioorg Med Chem; 2004 Mar; 12(6):1559-67. PubMed ID: 15018930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phytoestrogens act as estrogen agonists in an estrogen-responsive pituitary cell line.
    Stahl S; Chun TY; Gray WG
    Toxicol Appl Pharmacol; 1998 Sep; 152(1):41-8. PubMed ID: 9772198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effects of soybean isoflavones on relieving menopausal syndrome and osteoporosis].
    Liu Z; Wang Y
    Wei Sheng Yan Jiu; 2007 Sep; 36(5):643-5. PubMed ID: 18095582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isoflavones prevent endoplasmic reticulum stress-mediated neuronal degeneration by inhibiting tau hyperphosphorylation in SH-SY5Y cells.
    Park YJ; Jang YM; Kwon YH
    J Med Food; 2009 Jun; 12(3):528-35. PubMed ID: 19627200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isoflavones made simple - genistein's agonist activity for the beta-type estrogen receptor mediates their health benefits.
    McCarty MF
    Med Hypotheses; 2006; 66(6):1093-114. PubMed ID: 16513288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soybean phytoestrogen intake and cancer risk.
    Adlercreutz CH; Goldin BR; Gorbach SL; Höckerstedt KA; Watanabe S; Hämäläinen EK; Markkanen MH; Mäkelä TH; Wähälä KT; Adlercreutz T
    J Nutr; 1995 Mar; 125(3 Suppl):757S-770S. PubMed ID: 7884562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dietary soy isoflavones inhibit estrogen effects in the postmenopausal breast.
    Wood CE; Register TC; Franke AA; Anthony MS; Cline JM
    Cancer Res; 2006 Jan; 66(2):1241-9. PubMed ID: 16424064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.